Aptevo Therapeutics (NASDAQ:APVO) Coverage Initiated at StockNews.com

StockNews.com assumed coverage on shares of Aptevo Therapeutics (NASDAQ:APVO – Free Report) in a report published on Monday. The firm issued a sell rating on the biotechnology company’s stock. Aptevo Therapeutics Stock Performance Shares of APVO stock opened at $0.35 on Monday. Aptevo Therapeutics has a twelve month low of $0.28 and a twelve month […]

Leave a Reply

Your email address will not be published.

Previous post Genelux (NASDAQ:GNLX) Lifted to Strong-Buy at Roth Capital
Next post Canaccord Genuity Group Cuts Alarum Technologies (NASDAQ:ALAR) Price Target to $28.00